Katrina Thornber, Author at European Medical Journal - Page 16 of 35

A Breakthrough for Spinal Cord Injuries with Neural Stem Cell Transplants

Long-term trial finds neural stem cell transplants safe and shows neurological gains in spinal cord injury patients.

Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy

Aficamten improves symptoms, biomarkers, and quality of life in nonobstructive hypertrophic cardiomyopathy, promising better treatment options.

EACVI/ESC Scientific Statement: Improving Women’s Cardiovascular Care with Tailored Imaging

Exploring how cardiovascular imaging can better address the unique risks and outcomes of heart disease in women.

New siRNA Therapy Cuts Triglycerides by 57% in Severe Hypertriglyceridemia

Plozasiran significantly reduced triglycerides by 57% in severe hypertriglyceridemia, showing promise as a new treatment option.

Redefining Parkinson's and Lewy Body Dementia with a Biological Staging System

A new biological definition of Parkinson’s and dementia with Lewy bodies proposes an integrated staging system for research.

High Diagnostic Accuracy for Alzheimer’s Disease with Plasma p-Tau217

Plasma p-tau217 immunoassay shows high diagnostic accuracy for Alzheimer’s disease pathology, aiding early detection.

A Unified Diagnostic Criteria for Multiple Sclerosis Revolutionises Diagnosis

The study supports a unified set of diagnostic criteria for multiple sclerosis, improving accuracy in diagnosing progressive disease forms.

Machine Learning Advances Prognosis in Hypoxic-Ischemic Encephalopathy

Machine learning models using MRI improve neurodevelopmental predictions in neonates with hypoxic-ischemic encephalopathy.

Novel Non-Invasive Biomarkers for Liver Fibrosis in Obese Adolescents

These findings suggest that dihydroxyacetone phosphate, along with alanine transaminase, could serve as a valuable non-invasive biomarker for liver fibrosis.

Higher Risk of Dementia in Football Players Due to Headers

Study links high dementia risk in ex-soccer players to head impacts, not general health and lifestyle factors.